Meet the Fund Manager
Joseph ConstableNon Executive Director and Portfolio ManagerHGL Limited (Hancock & Gore)
Friday, 3rd December 12pm (AEDT)
This exclusive event gives investors unprecedented access to Australia’s leading fund managers to hear about their favourite companies, unique market insights, and the opportunity to ask questions.
This is an opportunity to hear from Joseph Constable, Non Executive Director & Portfolio Manager at HGL Limited.
Join Joseph to learn about:
- HGL Limited’s three favourite stocks
- Market insights and outlook
- Investment strategy and approach
This is a live and interactive online session, and participants are encouraged to ask questions. Joining only requires an internet connection. Spots are limited, so secure yours today.
HGL Limited (Hancock & Gore) is an active investment company that invests in small to medium-sized businesses with a sustainable competitive advantage and strong growth prospects and provides them with specialist management skills and equity capital to leverage their growth opportunities. HGL currently owns and operates with market leaders in five business units across five different market segments. Joseph Constable is a portfolio manager with more than five years’ experience across capital markets and is a former investment manager at Supervised Investments Australia with previous funds management experience at Smith and Williamson (UK) and Hunter Hall International.
Luke Winchester Founder and Portfolio Manager
Luke Winchester, Founder and Portfolio Manager at Merewether Capital, started the company with the intention of applying his vast microcap investment knowledge to a new top-performing fund. Luke has over 10 years’ experience in microcap investing, most recently serving as Emerging Companies Portfolio Manager at Oracle Investment Management.
Robert Calnon OC Funds Management
Hear about OC Funds Management, whose microcap fund was recently crowned Australia’s best-performing microcap fund by Morningstar (total return over five years). Robert Calnon, one of OC’s three highly experienced portfolio managers, shares his smallcap investing insights with us.
Matt McNamara Horizon 3 Biotech
Matt is a specialist in human healthcare technology and is passionate about investing in the commercialisation of this industry. He has spent more than 30 years in the healthcare and medical sciences sector and has more than 20 years’ experience as a venture capitalist. His business acumen and strong background in the life sciences sector make him one of the industry’s most credible investment voices.